
基于cBD3的衍生肽对犬皮肤源多药耐药菌的抑菌活性
吴方溶, 欧阳明瑜, 赵逸轩, 王雨晴, 胡长敏
基于cBD3的衍生肽对犬皮肤源多药耐药菌的抑菌活性
Antibacterial activity of derivative peptide based on cBD3 against multidrug resistant bacteria from canine skin
目的 筛选犬皮肤源多药耐药菌,同时基于犬防御素设计衍生肽并探究其抗菌作用。 方法 通过K-B药敏纸片法对临床分离的菌株进行筛选,随后以犬β-防御素3(cBD3)的氨基酸序列为模板,采用氨基酸替换的方式对序列进行设计,选取优化肽cBD3-ABU进行化学合成,利用微量肉汤稀释法检测cBD3-ABU对多药耐药菌的抑菌活性。 结果 筛选获得8株犬皮肤源多药耐药菌;通过固相合成法获得纯度达95.61%的cBD3-ABU;cBD3对大肠杆菌、表皮葡萄球菌、伪中间型葡萄球菌和金黄色葡萄球菌的最小抑菌浓度分别为32、64、64、128 μg/mL,高浓度cBD3-ABU对犬皮肤源大肠杆菌、表皮葡萄球菌、伪中间型葡萄球菌、金黄色葡萄球菌的抑菌率分别为96.02%、81.85%、87.25%、98.91%。 结论 cBD3-ABU在体外具有良好的抑菌活性,具有进一步开发为治疗性药物的潜力。
Objectives The multidrug resistant bacteria from canine skin were screened. The derivative peptide based on canine β-defensin-3 (cBD3) was designed and its antibacterial activity was studied. Methods The clinically isolated strains were screened with K-B drug-sensitive disk method. Subsequently, the amino acid sequence of β-defensin-3 (cBD3) was used as a template to design the sequence with amino acid substitution. The optimized peptide cBD3-ABU was selected for chemical synthesis. The antimicrobial activity of cBD3-ABU against multidrug resistant bacteria was detected with broth microdilution method. Results 8 strains of multidrug resistant bacteria from canine skin were obtained through screening. CBD3-ABU with a purity of 95.61% was obtained through solid-phase synthesis. The minimum inhibitory concentration (MIC) of cBD3 against Escherichia coli, S.epidermidis, S.pseudintermedius, and S.aureus was 32, 64, 64, 128 μg/mL, respectively. The antibacterial rate of high concentration cBD3-ABU against Escherichia coli, Staphylococcus epidermidis, Staphylococcus pseudointermedius and Staphylococcusaureus from canine skin was 96.02%, 81.85%, 87.25%, and 98.91%, respectively. Conclusions CBD3-ABU has good antibacterial activity in vitro and has the potential to be further developed into therapeutic drugs.
犬β防御素-3 / 多药耐药菌 / 最小抑菌浓度 / 抑菌活性 / 耐药率
canine β-defensin-3 (cBD3) / multidrug resistant bacteria / minimum inhibitory concentrations (MIC) / antibacterial activity / drug resistance rate
S859.7
1 |
卢顺, 向敏, 高其双, 等. 哺乳动物防御素生物学研究进展[J]. 中国兽医杂志, 2014,50(2):61-64.
|
2 |
|
3 |
刘陶林, 张宜宸, 何季竺, 等. 狐β-防御素基因的组织分布及表达特性[J]. 中国兽医杂志, 2021,57(3):36-40.
|
4 |
|
5 |
|
6 |
徐海涛. 猪β-防御素-2的重组表达及体外抑菌和抗病毒试验研究[D]. 武汉: 华中农业大学, 2009.
|
7 |
|
8 |
|
9 |
|
10 |
|
11 |
|
12 |
朱永官, 欧阳纬莹, 吴楠, 等. 抗生素耐药性的来源与控制对策[J]. 中国科学院院刊, 2015,30(4):509-516.
|
13 |
薛占永, 刘伟, 张宁宁, 等. 犬细菌性皮肤病病原菌的分离鉴定与药敏试验[J]. 中国兽医杂志, 2008,44(12):57-58.
|
14 |
苏梦茹, 马培培, 李鑫鑫, 等. 9种抗菌药物对大肠埃希菌最小抑菌浓度的测定[J]. 动物医学进展, 2020,41(3):52-56.
|
15 |
赵国春, 扣泽华, 孔令聪, 等. β-防御素生理特性的研究进展[J]. 当代畜禽养殖业, 2020,10:17-20.
|
16 |
邱晓媛, 郭广振, 吴鹏鑫, 等. 防御素的生物学功能及其在畜牧业的应用研究进展[J]. 动物营养学报, 2022,7:1-6.
|
17 |
任艳蓉, 李传峰, 孟春春, 等. 犬β防御CBD122原核表达及其抗病毒活性研究[J]. 中国动物传染病学, 2022,7:1-11.
|
18 |
|
19 |
|
20 |
王宇光, 叶秋娟, 吴冬梅, 等. 生物催化法水解制备N-BOC-L-α-氨基丁酸[J]. 发酵科技通讯, 2016,45(3):129-132.
|
/
〈 |
|
〉 |